[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ArtsStocks Art🇺🇸🇮🇱🇺🇦
Art🇺🇸🇮🇱🇺🇦 posts on X about $ions, $alny, $bbio, art the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +111%
Mentions: X #
- X Week XX -XX%
- X Month XXX +20%
- X Months XXX +132%
Followers: XXX #
- X Week XXX -XXXX%
- X Month XXX +3.10%
- X Months XXX +81%
CreatorRank: undefined #
Social Influence
Social category influence stocks XXXXX% technology brands XXXX% currencies XXXX%
Social topic influence $ions 11.36%, $alny 9.09%, $bbio 6.82%, art 6.82%, $ibb 4.55%, $xbi 4.55%, $arwr 2.27%, ai 2.27%, vivo 2.27%, core XXXX%
Top accounts mentioned or mentioned by @otsociety @hall8jack @rnaianalyst @sonichedgefund @grok @markclvb @biotechch @occamstooth @biopharmadive @jmaraganore @mcdivot06 @nationallipid @lpadoc @drlipid @madmoneyoncnbc @ionispharma @bayer @gsk @matthewherper @adamfeuerstein
Top assets mentioned Ionis Pharmaceuticals, Inc. Common Stock (IONS) Alnylam Pharmaceuticals, Inc. (ALNY) BridgeBio Pharma, Inc. Common Stock (BBIO) Bitcoin Incognito (XBI) Arrowhead Research Corporation (ARWR) Sarepta Therapeutics, Inc. (SRPT) AstraZeneca PLC (AZN)
Top Social Posts
Top posts by engagements in the last XX hours
"$alny gets subpoenaed. #Amvuttra is a high-cost drug and is administered under Medicare Part B its pricing and reporting are under significant government scrutiny. subpoena represents an investigation into the accuracy and compliance of Alnylam's government drug price. $bbio"
X Link 2025-12-04T23:09Z XXX followers, XXX engagements
"AI: siRNA is a double-stranded large highly charged nucleic acid ✔ It REQUIRES specific chemical modifications to survive in vivo ✔ Those modifications are OWNED by Ionis (and licensed by Alnylam) What this means: **Arrowheads delivery is not Arrowheads. $arwr"
X Link 2025-11-24T16:10Z XXX followers, XXX engagements
"@Hall8Jack X. Patent landscape. This is one of the most misunderstood topics among retail investors. Ionis owns the core chemistries: Phosphorothioate backbone 2-O-methyl 2-MOE 2-F LNA-derivative protection multiple bioconjugate patents intracellular"
X Link 2025-11-24T17:00Z XXX followers, XXX engagements
"Just for clarity: Only Ionis and #Sarepta (not original name) survived from the beginning. Many others tried and failed. $ions $srpt"
X Link 2025-11-27T17:56Z XXX followers, XXX engagements
"The task in front of $alny $bbio and its partner Bayer as well as potentially $azn and $Ions is how they can differentiate themselves from generic #tafamidis"
X Link 2025-12-04T15:09Z XXX followers, XXX engagements
"@GeneInvesting Why $ions Monia consistently states theres lots of room for improvement. More than half do worse. $alny $bbio"
X Link 2025-12-04T23:06Z XXX followers, XXX engagements
"Surprise its not down more with the justice department investigation into pricing. $ALNY is down XXXX% to $XXXXXX. Check it out on Yahoo Finance"
X Link 2025-12-05T19:13Z XXX followers, XXX engagements
"$ions #Ono #Onopharma $ibb $xbi @OTSociety #hematology #ASH25"
X Link 2025-12-07T16:48Z XXX followers, XXX engagements
"Ono prepared to take #IonisPharma PV drug into phase X. #ASH25 @endpts @BPharmCatalyst @EHA_Hematology @HematologyAdv"
X Link 2025-12-07T16:57Z XXX followers, XXX engagements